Neuland Laboratories per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹387.97₹283.71₹202.74₹233.89₹127.45
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹387.97₹283.71₹202.74₹233.89₹127.45
₹1,453.02₹1,453.02₹1,181.97₹994.31₹770.59
₹1,838.54₹1,568.14₹1,144.79₹1,208.16₹923.37
—₹268.73₹246.02₹202.45₹183.88
−₹38.27−₹38.27₹85.98₹91.09₹132.62
—₹11.93₹13.92₹9.95₹4.97
1.31.31.31.31.3
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NEULANDLAB₹18,695.00

Neuland Laboratories Ltd.

· Pharma & Health
₹ CrorePeersDIVISLABLAURUSLABSNHNATCOPHARMLALPATHLABSAILIFECOHANCEASTERDMMcap ₹24,117 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS127.45233.89202.74283.71387.97
Diluted EPS127.45233.89202.74283.71387.97
Book Value per Share770.59994.311,181.971,453.021,453.02
Revenue per Share923.371,208.161,144.791,568.141,838.54
Cash Flow per Share183.88202.45246.02268.73—
Free Cash Flow per Share132.6291.0985.98-38.27-38.27
Dividends per Share4.979.9513.9211.93—
Shares Outstanding (cr)1.31.31.31.31.3
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.